Science

A DRUG used safely in adult clinical trials appears promising for some children with an aggressive form of cancer. Around 150 Australian children are diagnosed each year with acute lymphoblastic leukaemia. Around 15 per cent of them will have an aggressive and hard- to- treat subtype, T- ALL. Prof Richard Lock and Dr Donya Moradi Manesh from the Childrens Cancer Institute say they’ve shown a drug known as PR- 1042 is effective against laboratory models of aggressive T- ALL.